COMMUNIQUÉS West-GlobeNewswire

Adamas Announces Final Results from the Two-Year Phase 3 Open-Label Study of GOCOVRI™ in Parkinson’s Disease Patients with Dyskinesia

19/04/2018 - 11:30

-- Patients receiving GOCOVRI experienced long-term durability for up to two years -- -- Safety profile was consistent with previously-published controlled Phase 3 studies -- EMERYVILLE, Calif., April 19, 2018 (GLOBE [...]

Oasmia has completed a private placement of new convertible instruments in a total amount of SEK 26,000,000

19/04/2018 - 08:45

Uppsala, Sweden April 19, 2018 – Oasmia Pharmaceutical AB (publ) (“Oasmia” or the “Company”) hereby announces that the Company has completed a private placement of a convertible loan in the amount of SEK 26,000,000 with [...]

Motif Bio Announces New Iclaprim Data being Presented at ECCMID 2018

19/04/2018 - 08:00

NEW YORK, April 19, 2018 (GLOBE NEWSWIRE) -- Positive efficacy and safety highlights from Phase 3 REVIVE-2 trial in ABSSSI Potential to avoid costs related to vancomycin-associated acute kidney injury in ABSSSI Data [...]

Herantis Pharma awarded Innovation prize of the Chemical Industry Federation of Finland

19/04/2018 - 07:30

Herantis Pharma awarded Innovation prize of the Chemical Industry Federation of Finland Herantis Pharma Plc Press release 19 Apr 2018 at 8:30 am The Innovation prize 2018 of Finland's Chemical Industry Federation was [...]

Novartis appoints John Tsai Head of Global Drug Development and Chief Medical Officer

19/04/2018 - 07:16

Basel, April 19, 2018 - Novartis announced today the appointment of John Tsai, M.D. as Head of Global Drug Development (GDD) and Chief Medical Officer. Dr. Tsai will join Novartis on May 1, 2018, and will be based in [...]

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

19/04/2018 - 07:06

REGULATED INFORMATION GHENT, Belgium, 19 April 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]

Novartis delivered a strong first quarter and acted to become a more focused medicines company

19/04/2018 - 07:02

Net sales grew 4% (cc[1], +10% USD) mainly driven by: Entresto grew to USD 200 million, +126% (cc) driven by increased uptake world wide Cosentyx was USD 580 million, +35% (cc) with strong growth in all indications and [...]

Novartis a réalisé une bonne performance au premier trimestre et agi pour devenir une entreprise plus centrée sur les médicaments

19/04/2018 - 07:02

Hausse du chiffre d'affaires net de 4% (tcc[1], +10% USD), stimulée principalement par: Entresto , qui a atteint USD 200 millions, soit +126% (tcc), soutenu par son adoption croissante dans le monde entier Cosentyx qui [...]

Curetis Launches CE-IVD Marked Unyvero Urinary Tract Infection (UTI) Cartridge at ECCMID 2018

19/04/2018 - 07:02

Curetis Launches CE-IVD Marked Unyvero Urinary Tract Infection (UTI) Cartridge at ECCMID 2018 UTI panel covers 103 diagnostic targets 443-patient multi-center study demonstrates overall weighted average sensitivity of [...]

Idorsia announces financial results for the first quarter 2018

19/04/2018 - 07:01

Allschwil, Switzerland - 19 April 2018 Idorsia Ltd (SIX: IDIA) today announced its financial results for the first quarter of 2018. Jean-Paul Clozel, MD and Chief Executive Officer, commented : "We are advancing four [...]

Bone Therapeutics Notice of Full Year 2017 Results

19/04/2018 - 07:01

Press release Bone Therapeutics Notice of Full Year 2017 Results Results to be announced on Wednesday 25 April 2018 Gosselies, Belgium, 19 April 2018, 7am CEST - BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), [...]

Bone Therapeutics publiera ses résultats financiers 2017, le mercredi 25 avril 2018

19/04/2018 - 07:01

Communiqué de presse Bone Therapeutics publiera ses résultats financiers 2017, le mercredi 25 avril 2018 Gosselies, Belgique, le 19 avril 2018, 7h00 CEST - BONE THERAPEUTICS (code Euronext Bruxelles et Paris : BOTHE, [...]

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

19/04/2018 - 07:01

REGULATED INFORMATION GHENT, Belgium, 19 April 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]

Aeglea BioTherapeutics Prices Public Offering of Common Stock

19/04/2018 - 04:50

AUSTIN, Texas, April 18, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc., (Nasdaq: AGLE ) a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with [...]

Apellis Pharmaceuticals Announces Pricing of Offering of Common Stock

19/04/2018 - 03:26

CRESTWOOD, Ky. and WALTHAM, Mass., April 18, 2018 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS ), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds [...]

Surface Oncology Announces $119.5 Million Aggregate Financing, Consisting of $108.0 Million Initial Public Offering and $11.5 Million Concurrent Private Placement

19/04/2018 - 03:00

CAMBRIDGE, Mass., April 18, 2018 (GLOBE NEWSWIRE) -- Surface Oncology, Inc. (“Surface”) (Nasdaq: SURF ), a clinical-stage immuno-oncology company developing next-generation antibody therapies that target the tumor [...]

Health Point Productions' Gene Wilder Bio-Documentary Moving Forward

18/04/2018 - 23:25

New Film on Beloved Star’s Life & his Battle with Alzheimer's Disease LOS ANGELES, April 18, 2018 (GLOBE NEWSWIRE) -- "Gene Wilder, a prolific actor and screenwriter best known for such classic films: Young [...]

National Research Corporation to Broadcast its 2018 First Quarter Conference Call Live on the Internet

18/04/2018 - 23:00

Lincoln, Nebraska, April 18, 2018 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ/:NRC) today announced that it will provide an online web simulcast of its 2018 first quarter conference call on Wednesday, May [...]

LeMaitre Vascular Will Announce First Quarter 2018 Earnings Results on April 25, 2018

18/04/2018 - 22:35

BURLINGTON, Mass., April 18, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT ) announced today that it will release its first quarter 2018 financial results on Wednesday, April 25, 2018, after the market [...]